CanaQuest Medical Corp. (CANQF)
0.0001
0.00 (0.00%)
USD |
OTCM |
Dec 12, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 0.002M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | -99.73% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | -- |
| Price to Book Value | -- |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | -- |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 99.98% |
Profile
| CanaQuest Medical Corp. is a pharmaceutical company, which is focused on the medical cannabis products, utilizing cannabinoid molecules, and other botanical compounds. The firm as developed Mentanine, Omega3 compounds + CBD pharma grade isolate, which is used for mental health issues inside the central nervous system and Mentabinol, THC + L-Theanine formulation, which is an alternative to all other THC products, addressing anxiety, depression, schizophrenia, and post traumatic stress disorder. The company was founded by Paul Ramsay and Richard J. Rusiniak on October 7, 2008 and is headquartered in Mississauga, Canada. |
| URL | http://www.canaquest.com |
| Investor Relations URL | N/A |
| HQ State/Province | Ontario |
| Sector | |
| Industry | |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Ratings
Profile
| CanaQuest Medical Corp. is a pharmaceutical company, which is focused on the medical cannabis products, utilizing cannabinoid molecules, and other botanical compounds. The firm as developed Mentanine, Omega3 compounds + CBD pharma grade isolate, which is used for mental health issues inside the central nervous system and Mentabinol, THC + L-Theanine formulation, which is an alternative to all other THC products, addressing anxiety, depression, schizophrenia, and post traumatic stress disorder. The company was founded by Paul Ramsay and Richard J. Rusiniak on October 7, 2008 and is headquartered in Mississauga, Canada. |
| URL | http://www.canaquest.com |
| Investor Relations URL | N/A |
| HQ State/Province | Ontario |
| Sector | |
| Industry | |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |